American Association for Cancer Research

Table 1.

Acrylamide and glycidamide adduct values in a convenience sample

	Age (y)	Acrylamide adducts (pmol/g Hb)	Glycidamide adducts (pmol/g Hb)	Glycidamide to acrylamide adduct ratio	Cotinine (ng/mL)
Total (N = 161)
Median	34	109	55	0.61	29
Range	18-66	7-610	4-364	0.03-1.14	N.D.-546
(5th-95th Percentile)	(21-50)	(32-342)	(20-188)	(0.33-0.97)	(0.02-372)
Men (N = 94)
Median	36	154*	81*	0.55^†	119^‡
Range	19-64	20-610	4-364	0.03-1.14	N.D.-546
(5th-95th Percentile)	(21-51)	(35-435)	(18-212)	(0.28-0.86)	(0.03-403)
Women (N = 67)
Median	30	58*	38*	0.69^†	0.11^‡
Range	18-66	7-399	7-260	0.38-1.13	N.D.-372
(5th-95th Percentile)	(20-46)	(33-247)	(22-160)	(0.46-1.03)	(0.02-304)

	Age (y)	Acrylamide adducts (pmol/g Hb)	Glycidamide adducts (pmol/g Hb)	Glycidamide to acrylamide adduct ratio	Cotinine (ng/mL)
Total (N = 161)
Median	34	109	55	0.61	29
Range	18-66	7-610	4-364	0.03-1.14	N.D.-546
(5th-95th Percentile)	(21-50)	(32-342)	(20-188)	(0.33-0.97)	(0.02-372)
Men (N = 94)
Median	36	154*	81*	0.55^†	119^‡
Range	19-64	20-610	4-364	0.03-1.14	N.D.-546
(5th-95th Percentile)	(21-51)	(35-435)	(18-212)	(0.28-0.86)	(0.03-403)
Women (N = 67)
Median	30	58*	38*	0.69^†	0.11^‡
Range	18-66	7-399	7-260	0.38-1.13	N.D.-372
(5th-95th Percentile)	(20-46)	(33-247)	(22-160)	(0.46-1.03)	(0.02-304)

Significant differences between men and women (P < 0.004).

Significant differences between men and women (P < 0.0001).

Significant differences between men and women (P < 0.001).